Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is WhiteSwell Medical's primary focus?
- WhiteSwell Medical is dedicated to improving the treatment of acute decompensated heart failure (ADHF), a major cause of repeat hospitalizations.
- What type of treatment is WhiteSwell Medical developing for ADHF?
- WhiteSwell Medical is developing a minimally invasive, catheter-based approach to enhance the lymphatic system's natural fluid-removal process in ADHF patients.
- When was WhiteSwell Medical founded?
- WhiteSwell Medical was founded in September 2014.
- How much funding has WhiteSwell Medical raised in total?
- WhiteSwell Medical has raised a total of $30,000,000 USD.
- When did WhiteSwell Medical complete its last funding round, and what type was it?
- WhiteSwell Medical completed a Series B funding round in December 2018.
- Which investors participated in WhiteSwell Medical's Series B round?
- The Series B round for WhiteSwell Medical included investors such as RA Capital Management and InCube Ventures.
- Where are WhiteSwell Medical's offices located?
- WhiteSwell Medical has offices in Shefayim, Israel; Galway, Ireland; and Palo Alto, California, USA.
- What was a key operational development for WhiteSwell Medical in December 2020?
- In December 2020, WhiteSwell Medical strengthened its patent portfolio for ADHF treatment with a newly issued U.S. patent.
- What was a significant staffing development for WhiteSwell Medical in January 2022?
- In January 2022, WhiteSwell Medical added experienced executives to its senior management team.